72
Participants
Start Date
November 14, 2016
Primary Completion Date
November 12, 2018
Study Completion Date
November 12, 2018
Placebo
UTTR1147A matching placebo will be administered SC.
UTTR1147A
UTTR1147A will be administered SC.
Semmelweis Egyetem, Budapest
Bispebjerg Hospital, Copenhagen
Kenezy Korhaz Rendelointezet, Debrecen
Odense Universitetshospital; Endokrinologisk Afdeling, Odense
DRC Gyogyszervizsgalo Kozpont Kft, Balatonfüred
Aalborg Universitetshospital, Aalborg
Clinical Research Associates Of Central Pa , Llc, Altoona
Hospital Universitario de Donostia, Donostia / San Sebastian
1Foot 2Foot Centre for Foot & Ankle Care PC, Suffolk
Universidad Complutense de Madrid, Madrid
Fundacion Hospital de Alcorcon, Alcorcón
GF Professional Research Group Corporation, Miami Lakes
Hospital Universitario Cruces, Barakaldo
Azienda Ospedaliera Universitaria Careggi, Florence
Steven M. Waldman, SC, Wauwatosa
Azienda Ospedaliero Universitaria Pisana, Pisa
Podiatry 1st, Belleville
Endeavor Clinical Trials PA, San Antonio
Animas Foot and Ankle, Durango
East Valley Foot and Ankle Specialists, Mesa
Center for Clinical Research Inc.; i, San Francisco
Futuro Clinical Trials, McAllen
Policlinico Universitario Campus Biomedico Di Roma; Farmacia, Rome
Hospital Universitario Germans Trias i Pujol, Badalona
Bradford Royal Infirmary, Bradford
Royal Derby Hospital; Medical School, Derby
Ipswich Hospital, Ipswich
St James University Hospital, Leeds
Kings College Hospital, London
University of East Anglia, Norfolk
Nottingham City Hospital, Nottingham
Northern General Hospital, Sheffield
Lead Sponsor
Genentech, Inc.
INDUSTRY